• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨形态发生蛋白-4(BMP-4)的骨形态发生蛋白IA型受体配体结合位点的鉴定。

Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.

作者信息

Hatta T, Konishi H, Katoh E, Natsume T, Ueno N, Kobayashi Y, Yamazaki T

机构信息

Structural Biology Unit, National Institute of Agrobiological Resources, Tsukuba, Ibaraki 305-8602, Japan.

出版信息

Biopolymers. 2000;55(5):399-406. doi: 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9.

DOI:10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9
PMID:11241215
Abstract

Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-beta (TGF-beta) superfamily of multifunctional cytokines. BMP induces its signal to regulate growth, differentiation, and apoptosis of various cells upon trimeric complex formation with two distinct type I and type II receptors on the cell surface: both are single-transmembrane serine/threonine kinase receptors. To identify the amino acid residues on BMP type I receptor responsible for its ligand binding, the structure-activity relationship of the extracellular ligand-binding domain of the BMP type IA receptor (sBMPR-IA) was investigated by alanine-scanning mutagenesis. The mutant receptors, as well as sBMPR-IA, were expressed as fusion proteins with thioredoxin in Escherichia coli, and purified using reverse phase high performance liquid chromatography (RP-HPLC) after digestion with enterokinase. Structural analysis of the parent protein and representative mutants in solution by CD showed no detectable differences in their folding structures. The binding affinity of the mutants to BMP-4 was determined by surface plasmon resonance biosensor. All the mutant receptors examined, with the exception of Y70A, displayed reduced affinities to BMP-4 with the rank order of decreases: I52A (17-fold) approximately F75A (15-fold) >> T64A (4-fold) = T62A (4-fold) approximately E54A (3-fold). The decreases in binding affinity observed for the latter three mutants are mainly due to decreased association rate constants while alterations in rate constants both, for association and dissociation, result in the drastically reduced affinities for the former two mutants. These results allow us to conclude that sBMPR-IA recognizes the ligand using the concave face of the molecule. The major ligand-binding site of the BMP type IA receptor consists of Phe75 in loop 2 and Ile52, Glu54, Thr62 and Thr64 on the three-stranded beta-sheet. These findings should provide a general basis for the ligand/type I receptor recognition in the TGF-beta superfamily.

摘要

骨形态发生蛋白(BMPs)属于多功能细胞因子的转化生长因子-β(TGF-β)超家族。BMP在与细胞表面两种不同的I型和II型受体形成三聚体复合物后,诱导其信号来调节各种细胞的生长、分化和凋亡:这两种受体均为单跨膜丝氨酸/苏氨酸激酶受体。为了鉴定BMP I型受体上负责其配体结合的氨基酸残基,通过丙氨酸扫描诱变研究了BMP IA型受体(sBMPR-IA)细胞外配体结合域的构效关系。突变受体以及sBMPR-IA在大肠杆菌中作为与硫氧还蛋白的融合蛋白表达,并在用肠激酶消化后通过反相高效液相色谱(RP-HPLC)纯化。通过圆二色光谱(CD)对溶液中的亲本蛋白和代表性突变体进行结构分析,结果显示它们的折叠结构没有可检测到的差异。通过表面等离子体共振生物传感器测定突变体与BMP-4的结合亲和力。除Y70A外,所有检测的突变受体对BMP-4的亲和力均降低,亲和力降低的顺序为:I52A(17倍)≈F75A(15倍)>>T64A(4倍)=T62A(4倍)≈E54A(3倍)。后三个突变体观察到的结合亲和力降低主要是由于缔合速率常数降低,而前两个突变体缔合和解离速率常数的改变均导致亲和力大幅降低。这些结果使我们能够得出结论,sBMPR-IA利用分子的凹面识别配体。BMP IA型受体的主要配体结合位点由环2中的苯丙氨酸75以及三链β折叠上的异亮氨酸52、谷氨酸54、苏氨酸62和苏氨酸64组成。这些发现应为TGF-β超家族中配体/I型受体识别提供一般基础。

相似文献

1
Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.骨形态发生蛋白-4(BMP-4)的骨形态发生蛋白IA型受体配体结合位点的鉴定。
Biopolymers. 2000;55(5):399-406. doi: 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9.
2
Crystal structure of the BMP-2-BRIA ectodomain complex.骨形态发生蛋白-2(BMP-2)与骨形成蛋白受体IA(BRIA)胞外结构域复合物的晶体结构
Nat Struct Biol. 2000 Jun;7(6):492-6. doi: 10.1038/75903.
3
A single residue of GDF-5 defines binding specificity to BMP receptor IB.生长分化因子5的单个残基决定了对骨形态发生蛋白受体IB的结合特异性。
J Mol Biol. 2005 Jun 24;349(5):933-47. doi: 10.1016/j.jmb.2005.04.015. Epub 2005 Apr 22.
4
The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.骨形态发生蛋白-2(BMP-2)与骨形态发生蛋白受体-IA(BMPR-IA)复合物的晶体结构及BMP-2拮抗剂的产生。
J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S7-14.
5
Molecular recognition of BMP-2 and BMP receptor IA.骨形态发生蛋白-2(BMP-2)与骨形态发生蛋白受体IA(BMP receptor IA)的分子识别
Nat Struct Mol Biol. 2004 May;11(5):481-8. doi: 10.1038/nsmb756. Epub 2004 Apr 4.
6
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.沉默的氢键可通过突变被激活,用于骨形态发生蛋白-2(BMP-2)与激活素IIB型受体的高亲和力相互作用。
BMC Struct Biol. 2007 Feb 12;7:6. doi: 10.1186/1472-6807-7-6.
7
Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2.重组骨形态发生蛋白受体IA胞外结构域及其与骨形态发生蛋白-2的2:1复合物的分离
FEBS Lett. 2000 Feb 25;468(2-3):215-9. doi: 10.1016/s0014-5793(00)01214-x.
8
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.骨形态发生蛋白-2拮抗剂源自受体骨形态发生蛋白受体-II低亲和力结合表位的改变。
EMBO J. 2000 Jul 3;19(13):3314-24. doi: 10.1093/emboj/19.13.3314.
9
Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites.重组人生长分化因子5的晶体结构:I型和II型受体结合位点相互作用的证据
Biochem Biophys Res Commun. 2005 Apr 15;329(3):1076-86. doi: 10.1016/j.bbrc.2005.02.078.
10
Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4.骨形态发生蛋白可溶性I型受体与骨形态发生蛋白-4之间的相互作用。
J Biol Chem. 1997 Apr 25;272(17):11535-40. doi: 10.1074/jbc.272.17.11535.

引用本文的文献

1
Reconstitution of morphogen shuttling circuits.形态发生因子穿梭回路的重建。
Sci Adv. 2023 Jul 14;9(28):eadf9336. doi: 10.1126/sciadv.adf9336. Epub 2023 Jul 12.
2
Morphogen gradient scaling by recycling of intracellular Dpp.通过细胞内Dpp循环实现形态发生素梯度缩放
Nature. 2022 Feb;602(7896):287-293. doi: 10.1038/s41586-021-04346-w. Epub 2021 Dec 22.
3
High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.利用生物层干涉测量法进行高通量骨形态发生蛋白/骨形态发生蛋白受体相互作用的测量。
Biointerphases. 2021 Jun 8;16(3):031001. doi: 10.1116/6.0000926.
4
Structural perspective of BMP ligands and signaling.骨形态发生蛋白(BMP)配体与信号传导的结构视角
Bone. 2020 Nov;140:115549. doi: 10.1016/j.bone.2020.115549. Epub 2020 Jul 27.
5
Treatment with soluble bone morphogenetic protein type 1A receptor fusion protein alleviates irradiation-induced bone loss in mice through increased bone formation and reduced bone resorption.可溶性1A型骨形态发生蛋白受体融合蛋白治疗通过增加骨形成和减少骨吸收减轻小鼠辐射诱导的骨质流失。
Am J Transl Res. 2020 Mar 15;12(3):743-757. eCollection 2020.
6
A soluble bone morphogenetic protein type 1A receptor fusion protein treatment prevents glucocorticoid-Induced bone loss in mice.可溶性骨形态发生蛋白1A型受体融合蛋白治疗可预防小鼠糖皮质激素诱导的骨质流失。
Am J Transl Res. 2019 Jul 15;11(7):4232-4247. eCollection 2019.
7
Heterogeneous nuclear ribonucleoprotein A1 regulates rhythmic synthesis of mouse Nfil3 protein via IRES-mediated translation.异质核核糖核蛋白 A1 通过 IRES 介导的翻译调控小鼠 Nfil3 蛋白的节律性合成。
Sci Rep. 2017 Feb 21;7:42882. doi: 10.1038/srep42882.
8
Structural Biology and Evolution of the TGF-β Family.转化生长因子-β家族的结构生物学与进化
Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):a022103. doi: 10.1101/cshperspect.a022103.
9
Production, Isolation, and Structural Analysis of Ligands and Receptors of the TGF-β Superfamily.转化生长因子-β超家族配体与受体的产生、分离及结构分析
Methods Mol Biol. 2016;1344:63-92. doi: 10.1007/978-1-4939-2966-5_4.
10
Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.转化生长因子β信号通路在衰老和骨关节炎关节中的调控及作用
Aging Dis. 2013 Dec 17;5(6):394-405. doi: 10.14336/AD.2014.0500394. eCollection 2014 Dec.